What is InnoCentive?
InnoCentive operates as a premier global marketplace for innovation, bridging the gap between complex organizational challenges and a vast, distributed network of expert solvers. The platform serves as a critical infrastructure for startups, academic institutions, and multinational corporations seeking to accelerate discovery through crowdsourced intelligence. By leveraging a diverse community of scientists, engineers, and subject matter experts, InnoCentive enables enterprises to bypass traditional R&D bottlenecks, fostering a collaborative environment where high-impact solutions are generated at scale. Its market position is unique, as it effectively democratizes access to specialized expertise while providing a structured framework for intellectual property exchange and collaborative problem-solving.
How much funding has InnoCentive raised?
InnoCentive has raised a total of $15.7M across 3 funding rounds:
Series A
$9M
Series B
$6.5M
Debt
$150K
Series A (2006): $9M with participation from Omidyar Network and Lilly Ventures
Series B (2008): $6.5M led by Eli Lilly and Company and SAP
Debt (2020): $150K supported by PPP
Key Investors in InnoCentive
Omidyar Network
A philanthropic investment firm focused on shaping the digital revolution to promote shared prosperity and influence the intersection of technology and society.
Eli Lilly and Company
A global biopharmaceutical leader dedicated to research-driven innovation in medicine, providing both capital and deep scientific expertise to its portfolio partners.
SAP
A global leader in enterprise resource planning software, specializing in digital transformation solutions that streamline business processes for large-scale organizations.
What's next for InnoCentive?
With the recent infusion of capital, InnoCentive is well-positioned to deepen its integration into the enterprise digital transformation stack. The strategic focus will likely shift toward enhancing the platform's algorithmic matching capabilities, ensuring that complex technical challenges are routed to the most qualified solvers with greater precision. As corporations increasingly prioritize agile innovation models, InnoCentive's role as a facilitator of external R&D will become even more vital. Future growth will likely involve expanding its reach into emerging sectors such as synthetic biology and advanced materials, where the demand for rapid, cross-disciplinary problem-solving is at an all-time high. By maintaining its commitment to open innovation, the company is poised to remain a central hub for global intellectual capital.
See full InnoCentive company page
